• ¿Documento equivocado? Cámbialo gratis
  • Escrito por estudiantes que aprobaron
  • Inmediatamente disponible después del pago
  • Leer en línea o como PDF
Vender
¿Dónde estudias?
Tu idioma
Document preview thumbnail
Vista previa 4 fuera de 42 páginas
Examen

Nur 378 Exam 1 Pharmacology Complete Study Guide 2026

Document preview thumbnail
Vista previa 4 fuera de 42 páginas

NUR 378 EXAM 1 PHARMACOLOGY COMPLETE STUDY GUIDE 2026

Vista previa del contenido

NUR 378 EXAM 1 PHARMACOLOGY
COMPLETE STUDY GUIDE 2026

◉ Explain the most significant drug-drug interactions for warfarin.
Answer: - with Heparin --> increases bleeding
- with Aspirin --> hemorrhage
- with non-aspirin antiplatelet drugs --> increases risk of bleeding
- with Acetaminophen --> increases risk of bleeding


Summary:
- Drugs that promote anticoagulation --> increases effects of
warfarin
- Drugs that promote bleeding --> increases risk of hemorrhaging
- Drugs that decrease anticoagulation --> decreases effects of
warfarin


◉ What should the nurse keep in mind and teach the client
regarding drug-drug interactions and warfarin? Answer: Clients
should be informed of the potential hazardous interactions with
drugs that promote bleeding or avoid any drug not prescribed by the
provider

,◉ What assessments and preparations should the nurse perform
before administering warfarin? Answer: - Baseline data of vitals
- PT values
- Genetic testing for variants of CYP2C9 and VKORCI


◉ How will the nurse monitor a client on warfarin? Answer: -
Monitor Prothrombin Time (PT), record results in international
normalized ratio (INR): Range 2-3
- Daily first 5 days, 2x a week next 1-2 weeks, 1x a week next 1-2
months, 1x every 2-4 weeks after
- Below = increase dosage
- Above = decrease dosage


◉ What teaching will the nurse provide for a client prescribed
warfarin? Answer: - Promote Adherence
- Know the signs of bleeding
- Know the risk of drug interactions


◉ How will the nurse assess the efficacy of treatment with warfarin?
Answer: PT results are between 2-3 INR


◉ What is the treatment for warfarin overdose? Answer: Vitamin K1
(phytonadione) antagonizes warfarin action and reverse the
overdose

,2.5 mg PO or 0.5-1 mg IV


◉ What are the expected pharmacological effects of the direct
thrombin inhibitors (Ex. dabigatran etexilate)? Answer: Binds and
inhibits thrombin in the blood to prevent the conversion of
fibrinogen to fibrin and prevent activation of factor XIII, which
prevents conversion soluble fibrin to insoluble fibrin --> overall
leads to reduced platelet formation and platelets in the blood.


◉ What are the therapeutic indications of the direct thrombin
inhibitors? Answer: - Atrial Fibrillation:
- prevents stroke and systemic embolism in patients with non-
vavular atrial fibrillation
- DVT and PE
- Knee or Hip replacement
- DVT/PE treatment


◉ What is the adverse effect common to all of the direct thrombin
inhibitors? Answer: - Bleeding
- GI disturbances: dyspepsia, gastritis-like symptoms


◉ How will the nurse monitor a client on a direct thrombin inhibitor
infusion? Answer: - Platelet count

, ◉ What teaching will the nurse provide for a client prescribed a
direct thrombin inhibitor for prophylaxis therapy? Answer: Take
with meals to lower GI disturbances


◉ What are the expected pharmacological effects of the direct factor
Xa inhibitors (Ex. rivaroxaban)? Answer: Binds directly with Factor
Xa to inhibit production of thrombin


◉ What are the therapeutic indications of the direct factor Xa
inhibitors (Ex. rivaroxaban)? Answer: - Prevent DVT and PE
following hip and knee replacement
- Prevent Stroke in clients with atrial fibrillation
- Treat DVT and PE unrelated to orthopedic surgery


◉ What is the adverse effect common to all of the direct factor Xa
inhibitors? Answer: - Bleeding
- Spinal/Epidural hematoma


◉ What is the mechanism of action by which aspirin acts as an
antiplatelet drug? Answer: Inhibits cyclooxygenase to prevent
platelets from synthesizing TXA2, which prevents promotion of
platelet activation and vasoconstriction in VSM, resulting in
decreased risk of arterial thrombosis

Información del documento

Subido en
26 de enero de 2026
Número de páginas
42
Escrito en
2025/2026
Tipo
Examen
Contiene
Preguntas y respuestas
$12.99

¿Documento equivocado? Cámbialo gratis Dentro de los 14 días posteriores a la compra y antes de descargarlo, puedes elegir otro documento. Puedes gastar el importe de nuevo.
Escrito por estudiantes que aprobaron
Inmediatamente disponible después del pago
Leer en línea o como PDF

Seller avatar
Los indicadores de reputación están sujetos a la cantidad de artículos vendidos por una tarifa y las reseñas que ha recibido por esos documentos. Hay tres niveles: Bronce, Plata y Oro. Cuanto mayor reputación, más podrás confiar en la calidad del trabajo del vendedor.
TopGradeInsider
4.1
(14)
Vendido
194
Seguidores
1
Artículos
62508
Última venta
2 días hace



Por qué los estudiantes eligen Stuvia

Creado por compañeros estudiantes, verificado por reseñas

Calidad en la que puedes confiar: escrito por estudiantes que aprobaron y evaluado por otros que han usado estos resúmenes.

¿No estás satisfecho? Elige otro documento

¡No te preocupes! Puedes elegir directamente otro documento que se ajuste mejor a lo que buscas.

Paga como quieras, empieza a estudiar al instante

Sin suscripción, sin compromisos. Paga como estés acostumbrado con tarjeta de crédito y descarga tu documento PDF inmediatamente.

Student with book image

“Comprado, descargado y aprobado. Así de fácil puede ser.”

Alisha Student

Preguntas frecuentes